Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-027134

Niagen Bioscience, Inc. · NAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Ka Shing Li
10% Owner
Period of report
Nov 17, 2017
Accepted (ET)
Nov 21, 2017 · 12:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Nov 17, 2017P731,707$4.10A6,500,937D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses